Life Unchanging™
WE'RE CHANGING
PROSTATE TREATMENT,
SO LIVES DON'T HAVE TO.
Prostate cancer is the most common cancer in men, and treatment can often permanently change not only the patient’s life, but also the lives of their loved ones.
At Medlogical Innovations, our mission is to drive better outcomes in prostate cancer management with precision-engineered and purpose-designed technology. By minimising side effects, we’re empowering men to lead a normal and full life afterwards.

1
NIH National Cancer Institute - Prostate Cancer — Cancer Stat Facts.
https://seer.cancer.gov/statfacts/html/prost.html
1 in 8 men will be diagnosed with prostate cancer at some point during their lifetime.
2 in 3 men diagnosed with prostate cancer will have radical prostatectomy surgery or radiation therapy.
Prostate Cancer treatment today
is effective BUT may cause significant,
long lasting side effects
Side effects of traditional
Prostate Cancer treatment
can include:
• Urinary incontinence
• Fecal or bowel incontinence
• Sexual dysfunction
• Re-intervention due to failed
surgery or radiation therapy
• Depression
INTRODUCING
FOCAL THERAPY
Focal or targeted therapy aims to treat a specific lesion or area within the prostate gland. Systems can use various energy sources, including laser, to ablate and destroy tissue while preserving healthy prostate.

CLINICAL STUDY HIGHLIGHTS
Interim results from the ProFocal pivotal study are published. Manuscript for the Full results has been submitted for publication. Primary endpoints of safety and efficacy met.
2
Initial Clinical Trial of Focal Laser Ablation Utilizing ProFocal-Rx For Localized Prostate Cancer. Kam, J. et al. 2023. Journal of Urology Vol.209, Issue Supplement 4, e859

100
Patient Study
MRI within 72 hours, 3 month biopsy, functional outcomes @ 0, 3-6 months.

84%
Treatment Success
Avoid radical treatment after a single ProFocal procedure

0%
Urinary Incontinence
No urinary stress incontinence observed.

100%
Day Procedure
All cases performed as a day procedure

500
Patient Cases Completed
Clinical cases completed under Authorised Prescriber Scheme, Australian Government Dept of Health and Aged Care (2023).